🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT04722900
Recruiting Observational

PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes

NCT04722900 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2021-01-15
Last updated
2021-09-02

Condition(s) studied

Offspring Exposed to GDM and Control

Investigational drug(s) / intervention(s)

intrauterine exposure to elevated glucose levels

intrauterine exposure to elevated glucose levels: intrauterine exposure to elevated glucose levels

Study summary

Gestational diabetes is the most common complication during pregrancy. With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated. Treatment comprises modification of diet and in some cases taking medication. This treatment lowers undesirable events like macrosomia or premature birth. However, unitl gestational diabetes is diagnosed the fetus is exposed to increased intrauterine glucose levels. The long-term effects of a well-managed gestational diabetes on the development of the offspring is still not well understood. Therefore, the PREG - Offspring study investigates several aspects of development in children from healthy and gestational diabetes mothers until adulthood.

Eligibility

Sex
ALL
Min age
6 Years
Max age
17 Years
Healthy volunteers
Accepted
Inclusion Criteria: * signed informed consent provided by child and parent * documented oral glucose tolerance test of the mother during pregnancy * adequate management of gestational diabetes until birth Exclusion Criteria: * severe malformation that makes an examination impossible * existent of coagulation disorder with increased risk of bleeding after blood sampling

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Tübingen Tübingen Germany Recruiting

More University Hospital Tuebingen trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04722900 on ClinicalTrials.gov ↗ ← All trials in Germany